TrialDiabetes care2013

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).

Matthew C Riddle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.